Clinical Profile and Surgical Outcomes of Pediatric Umbilical Pilonidal Sinus
Abstract
Abstract
Introduction
Umbilical pilonidal sinus (UPS) is a rare form of pilonidal disease (PNS) predominantly affecting young individuals. Owing to its low incidence, data on risk factors and optimal management remain limited. This study aimed to investigate UPS in the pediatric age group and evaluate the efficacy of surgical management.
Methods
A retrospective, single-center cohort study was conducted over five years, including patients aged ≤18 years diagnosed with UPS. Clinical, demographic, and risk factor data were collected from medical records. All patients underwent surgical management under local anesthesia, with follow-up to assess healing and recurrence. Descriptive statistical analysis was performed using SPSS version 27.0.
Results
A total of 42 cases (mean age 16.4 ± 1.48 years) were included. Males comprised 22 (52.4%) of cases. Dense body hair was observed in 29 (69.0%) of patients, and 15 (35.7%) reported a positive family history, and obesity was common (median body mass index (BMI) was 25.9 (IQR: 22.5–29.0)). Surgical treatment achieved successful healing in 40 (95.2%) of cases, with a low recurrence rate of 1 (2.4%).
Conclusion
Surgical management showed favorable outcomes with high healing and low recurrence rates, supporting its effectiveness in pediatric patients. However, larger multicenter studies are needed to clarify risk factors and optimize management strategies.
Introduction
Pilonidal sinus (PNS) disease is the formation of a sinus tract…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.